A 12 weeks, randomized, double-blind, placebo-controlled human trial to evaluate the efficacy and safety of Angelica gigas N. extract powder(Nutragen) on joint health

Wonkwang University Oriental Medical Hospital, Jeonju0 个研究点目标入组 80 人开始时间: 待定最近更新: 2020年1月14日

试验速览

暂无简介。

•1) Males and females aged 50-80 years at the screening examination
•2) Participants currently with one or both knees pain
•3) Participants with 1~2 of Kellgren Lawrence grade(KL grade)
•4) Participants who have fully understand the information provided about the study voluntarily decided to participate and agree to comply with precautions

•1) Patients with a clinically significant disease requiring treatment (i.e., severe cardiovascular system, endocrine system, immune system, respiratory system, hepatobiliary system, kidney and urinary system, neuropsychiatric system, musculoskeletal inflammation, inflammatory disease, blood and tumor disease, gastrointestinal disease, etc.)
•2) Patients who take medicine for joint health and intake health functional food within a month prior to the screening examination
•3) Patients with a history of antipsychotic medication use within 2 months prior to the screening examination
•4)Patients who have participated in other clinical trials within 3 months prior to the screening examination
•5)Patients who are judged ineligible to participate in the trial by the principal investigator for other reasons, including laboratory test outcomes

发起方

Wonkwang University Oriental Medical Hospital, Jeonju